Summary
The COVID-19 pandemic proved highly consequential for the pharmaceutical industry as public debate around vaccine and drug development reached a fever pitch. But under the surface, this black swan event expedited the implementation of underutilized digital capabilities, like real-world data (RWD) and decentralized clinical trials (DCTs). This report helps healthcare leaders understand and approach the most critical age-of-the-customer trends that will impact the industry in 2022.
Log in to continue reading
Client log in
Welcome back. Log in to your account to continue reading this research.
Become a client
Become a client today for these benefits:
- Stay ahead of changing market and customer dynamics with the latest insights.
- Partner with expert analysts to make progress on your top initiatives.
- Get answers from trusted research using Izola, Forrester's genAI tool.
Purchase this report
This report is available for individual purchase ($1495).